Norfloxacin ophthalmic Pregnancy and Breastfeeding Warnings
Brand names: Chibroxin
Norfloxacin ophthalmic Pregnancy Warnings
Norfloxacin ophthalmic has been assigned to pregnancy category C by the FDA. Animal data have revealed evidence of embryolethality. There are no controlled data in human pregnancy. Cartilage damage and arthropathies have been reported in immature animals giving rise to concern over effects on fetal bone formation. Norfloxacin ophthalmic is only recommended for use during pregnancy when benefit outweighs risk.
Norfloxacin ophthalmic Breastfeeding Warnings
There are no data on the excretion of norfloxacin ophthalmic into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue the drug or to discontinue nursing, taking into account the importance of the drug to the mother.
See also
References for pregnancy information
- (2001) "Product Information. Chibroxin (norfloxacin ophthalmic)." Merck & Co., Inc
References for breastfeeding information
- (2001) "Product Information. Chibroxin (norfloxacin ophthalmic)." Merck & Co., Inc
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
